down arrow

Hester Bios

36
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE782E01017
  • NSEID: HESTERBIO
  • BSEID: 524669
INR
1,666.85
68.85 (4.31%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 6.4 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Hester Bios Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
31.00
40.00
53.00
50.00
41.00
56.00
Adjustment
24.00
12.00
11.00
20.00
20.00
17.00
Changes In working Capital
3.00
-20.00
-38.00
1.00
-13.00
-12.00
Cash Flow after changes in Working Capital
59.00
31.00
25.00
71.00
47.00
62.00
Cash Flow from Operating Activities
48.00
23.00
8.00
58.00
36.00
46.00
Cash Flow from Investing Activities
-22.00
-76.00
-116.00
-42.00
-72.00
-21.00
Cash Flow from Financing Activities
-26.00
41.00
111.00
-18.00
18.00
2.00
Net Cash Inflow / Outflow
0.00
-11.00
3.00
-2.00
-17.00
28.00
Opening Cash & Cash Equivalents
13.00
24.00
21.00
23.00
40.00
12.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
12.00
13.00
24.00
21.00
23.00
40.00
Compare Cash Flow Results of Hester Bios
Markets Mojo
Figures in Rs cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
31.95
2399.36
-2,368.00
-98.67%
Adjustment
24.22
212.2
-188.00
-88.59%
Changes In working Capital
3.63
20.42
-17.00
-82.22%
Cash Flow after changes in Working Capital
59.8
2631.98
-2,572.00
-97.73%
Cash Flow from Operating Activities
48.13
2152.45
-2,104.00
-97.76%
Cash Flow from Investing Activities
-22.5
-2080.52
2,058.00
98.92%
Cash Flow from Financing Activities
-26.05
5.27
-31.00
-594.31%
Net Cash Inflow / Outflow
-0.41
77.19
-77.00
-100.53%
Opening Cash & Cash Equivalents
13.16
304.82
-291.00
-95.68%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
12.75
382.01
-370.00
-96.66%
Cash Flow - Snapshot (Consolidated) - Mar'24
stock-summary

YoY Growth in year ended Mar 2024 is 103.94% vs 170.95% in Mar 2023

Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
48.13
23.60
103.94%